MARATHON
Report
- Report Number
- 2029214-2017-00294
- Event Type
- Injury
- Date Received
- March 30, 2017
- Date of Event
- January 1, 2009
- Report Date
- November 16, 2016
- Manufacturer
- MEDTRONIC COVIDIEN
- Product Code
- KRA
- PMA / PMN Number
- K093750
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: GAO KUN, YANG XIN-JIAN, MU SHI-QING, ET AL. "EMBOLIZATION OF BRAIN ARTERIOVENOUS MALFORMATIONS WITH ETHYLENE VINYL ALCOHOL COPOLYMER: TECHNICAL ASPECTS. CHINESE MEDICAL JOURNAL 2009;122(16):1851-1856. THE DEVICE WAS NOT RETURNED FOR EVALUATION; WITHOUT RETURN OF THE DEVICE, NO DEFINITIVE CONCLUSIONS CAN BE DRAWN REGARDING THE CLINICAL OBSERVATION. MDRS RELATED TO THIS REPORT: 2029214-2017-00292 2029214-2017-00293 2029214-2017-00294. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION THROUGH REVIEW OF LITERATURE THAT DURING ONYX EMBOLIZATION A MICROCATHETER WAS GLUED IN THE AVM OF 5 PATIENTS AND CUT OFF IN THE GROIN BECAUSE OF THE LONG INJECTION TIME AND REFLUX LENGTH. OF THESE FIVE PATIENTS, THREE EXHIBITED NO NEW NEUROLOGICAL DEFICIT, ONE PATIENT WITH TRANSIENT DIPLOPIA, AND ANOTHER PATIENT WITH TRANSIENT RIGHT HEMIPARESIS. DMSO COMPATIBLE CATHETERS WERE USED (ULTRAFLOW AND MARATHON) HOWEVER THE MODELS OF THE CATHETERS THAT WERE GLUED TO THE AVM WERE NOT PROVIDED. THIS COHORT WAS FROM SEPTEMBER 2003 TO NOVEMBER 2007, 115 PATIENTS (43 WOMEN AND 72 MEN, WITH A MEAN AGE OF 29 YEARS) WITH BAVMS WERE ENDOVASCULARLY TREATED WITH ONYX IN OUR DEPARTMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 227284 | MARATHON | CATHETER, CONTINUOUS FLUSH | KRA | MEDTRONIC COVIDIEN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 29 YR | Disability |